Recruiting NA Infertility

New treatment option for Infertility

Official title The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization

ClinicalTrials.gov ID: NCT06319573

What this study is testing

What it's testing
This study will be conducted in two phases. In the first phase, research subjects will be assigned to receive standard counseling.
  • This is a blinded study.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 43, women only

You may be able to join if

  • Patients between 18-43 in age and their healthcare providers have determined that IVF treatment using the patients' own eggs is indicated.

You likely can't join if

  • specific to this study only (these are not contraindications to using the Univfy® PreIVF Report):
  • Same sex couples
  • Patients undergoing DuoStim and/or PGT-M/-SR
  • Patients considering egg freezing rather than IVF
  • Patients considering the use of donor eggs or gestational carrier Patients with contraindications to receiving the Univfy® PreIVF Report For Patients...
  • Patients who are perimenopausal or menopausal
See the full eligibility criteria
Who can join
  • Patients between 18-43 in age and their healthcare providers have determined that IVF treatment using the patients' own eggs is indicated.
What rules you out
  • specific to this study only (these are not contraindications to using the Univfy® PreIVF Report):
  • Same sex couples
  • Patients undergoing DuoStim and/or PGT-M/-SR
  • Patients considering egg freezing rather than IVF
  • Patients considering the use of donor eggs or gestational carrier Patients with contraindications to receiving the Univfy® PreIVF Report For Patients Under 40 Using Their Own Eggs. Those contraindications are:
  • Patients who are perimenopausal or menopausal
  • Patients who have very poor IVF results in the past, including:
  • extremely poor oocyte/embryo quality, no embryos to transfer,
  • no euploid embryos on PGT-A, no blastocysts in extended culture

The study team makes the final eligibility decision.

Where it's taking place

  • Barcelona, Spain
  • Madrid, Spain

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 43 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Barcelona, Spain; Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.